Company news

Neuronetics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults

September 18, 2024

NeuroStar® Releases Software Upgrades to Elevate Patient Care

September 15, 2024

NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories

September 2, 2024

NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University

August 19, 2024

Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results

August 11, 2024

Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge

August 11, 2024

NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month

July 31, 2024

Neuronetics to Present at the Canaccord Genuity 44th Annual Growth Conference

July 30, 2024

Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors

July 29, 2024

Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call

July 28, 2024

Aetna Policy Update Expands TMS Availability for Adolescents With Depression

July 21, 2024

NeuroStar® Launches Better Me Provider Program Nationwide

June 30, 2024

NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting

June 12, 2024

Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference

May 22, 2024

Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents

May 14, 2024

Neuronetics Reports Record First Quarter 2024 Financial and Operating Results

May 6, 2024

NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month

April 30, 2024

Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call

April 22, 2024

New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital

April 9, 2024

NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

March 24, 2024

Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network

March 6, 2024

Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results

March 4, 2024

Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call

February 19, 2024

Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System

February 11, 2024

NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update

February 5, 2024

Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results

January 7, 2024

Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory

December 17, 2023

NeuroStar TMS Receives Expanded Regulatory Approval in Japan

December 3, 2023

Neuronetics to Present at the 35th Annual Piper Sandler Healthcare Conference

November 14, 2023

NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements

November 12, 2023

Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage

November 8, 2023

Neuronetics Reports Third Quarter 2023 Financial and Operating Results

November 6, 2023

Neuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call

October 23, 2023

Neuronetics Draws Down Remaining $22.5 Million Available Under Credit Facility

October 2, 2023

In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression

September 11, 2023

NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards

August 20, 2023

Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform

August 13, 2023

Neuronetics Reports Record Second Quarter 2023 Financial and Operating Results

August 7, 2023

Neuronetics to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call

July 24, 2023

Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans

July 18, 2023

NeuroStar Achieves Milestone Regulatory Clearance in South Korea

July 16, 2023

NeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For Partnership With Drew Robinson, Mental Health Advocate and Former MLB Player

July 10, 2023

Neuronetics Receives 510(k) Clearance for OCD MT Cap for NeuroStar Advanced Therapy

June 11, 2023

Neuronetics investing in NeuroStar awareness as drug-free treatment alternative for depression

May 29, 2023

Neuronetics Announces Increased TMS Access Through BlueCross BlueShield Of Michigan

May 25, 2023

Neuronetics to Present at the William Blair 43rd Annual Growth Stock Conference

May 23, 2023

New Depression Barometer Survey Shows Patients Are Stopping Treatment Due to Dissatisfaction

May 22, 2023

Neuronetics Wins 2023 Bell Seal for Workplace Mental Health

May 14, 2023

Neuronetics to Present at the JMP Securities Life Sciences Conference

May 8, 2023

Neuronetics Reports Record First Quarter 2023 Financial and Operating Results

May 8, 2023

← Newer news releases · Older news releases →

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 14 decks. Every deck is listed under its year.